Form 4 Hims & Hers Health, Inc. For: Feb 12 Filed by: Baird Melissa
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
Hims and Hers (HIMS) PT Raised to $85 at BTIG
February 18, 2025 5:20 AM ESTBTIG analyst David Larsen raised the price target on Hims and Hers (NYSE: HIMS) to $85.00 (from $35.00) while maintaining a Buy rating.
The analyst comments "Shares of both Hims and Hers Health (HIMS, Buy, $85 PT) and LifeMD (LFMD, Buy, $12 PT) are... More
